OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tuberculosis endotypes to guide stratified host-directed therapy
Andrew R. DiNardo, Tomoki Nishiguchi, Sandra L. Grimm, et al.
Med (2021) Vol. 2, Iss. 3, pp. 217-232
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Host-directed immunotherapy of viral and bacterial infections: past, present and future
Robert S. Wallis, Anne O’Garra, Alan Sher, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 121-133
Open Access | Times Cited: 158

Interferon- γ and infectious diseases: Lessons and prospects
Jean‐Laurent Casanova, John D. MacMicking, Carl Nathan
Science (2024) Vol. 384, Iss. 6693
Closed Access | Times Cited: 48

Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies
Divya Tiwari, Adrian R. Martineau
Seminars in Immunology (2022) Vol. 65, pp. 101672-101672
Open Access | Times Cited: 56

Recent advances in the treatment of tuberculosis
Ilaria Motta, Martin J. Boeree, Dumitru Chesov, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 9, pp. 1107-1114
Open Access | Times Cited: 36

Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes
Andrew R. DiNardo, Tanmay Gandhi, Jan Heyckendorf, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 3, pp. 2102263-2102263
Open Access | Times Cited: 33

Host-Directed Therapies for Tuberculosis
Eui-Kwon Jeong, Hyo-Ji Lee, Yu‐Jin Jung
Pathogens (2022) Vol. 11, Iss. 11, pp. 1291-1291
Open Access | Times Cited: 32

The integration of omics: A promising approach to personalized tuberculosis treatment
Priyanka Guha, Siddhartha Dutta, Krishna Murti, et al.
Medicine in Omics (2024) Vol. 12, pp. 100033-100033
Open Access | Times Cited: 7

Integrated transcriptomic analysis of human tuberculosis granulomas and a biomimetic model identifies therapeutic targets
Michaela T. Reichmann, Liku B. Tezera, Andrés F. Vallejo, et al.
Journal of Clinical Investigation (2021)
Open Access | Times Cited: 35

Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis
Ahmad Z. Bahlool, Sarinj Fattah, Andrew O’Sullivan, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1745-1745
Open Access | Times Cited: 23

Reinventing the human tuberculosis (TB) granuloma: Learning from the cancer field
Senait Ashenafi, Susanna Brighenti
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23

Inflammatory immune profiles associated with disease severity in pulmonary tuberculosis patients with moderate to severe clinical TB or anemia
Senait Ashenafi, Marco Giulio Loreti, Amsalu Bekele, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11

Endotypes and the Path to Precision in Moderate and Severe Traumatic Brain Injury
Tej D. Azad, Pavan P. Shah, Han Kim, et al.
Neurocritical Care (2022) Vol. 37, Iss. S2, pp. 259-266
Closed Access | Times Cited: 19

Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases
Joaquín Miguel Pellegrini, Jean‐Pierre Gorvel, Sylvie Mémet
Microorganisms (2022) Vol. 10, Iss. 7, pp. 1260-1260
Open Access | Times Cited: 19

Association between blood inflammatory status and the survival of tuberculosis: a five-year cohort study
Yating Ji, Qingyao Xie, Wei Wei, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials
Andrew R. DiNardo, Wilber Sabiiti, Stephen H. Gillespie, et al.
Frontiers in Antibiotics (2025) Vol. 4
Open Access

Pathogenesis of Post-Tuberculosis Lung Disease: Defining Knowledge Gaps and Research Priorities at the 2nd International Post-Tuberculosis Symposium
Sara C. Auld, Amy K. Barczak, William R. Bishai, et al.
American Journal of Respiratory and Critical Care Medicine (2024) Vol. 210, Iss. 8, pp. 979-993
Closed Access | Times Cited: 3

Artificial intelligence in tuberculosis: a new ally in disease control
Mairi McClean, Traian Constantin Panciu, Christoph Lange, et al.
Breathe (2024) Vol. 20, Iss. 3, pp. 240056-240056
Open Access | Times Cited: 3

Cell state transition analysis identifies interventions that improve control of Mycobacterium tuberculosis infection by susceptible macrophages
Shivraj M. Yabaji, Oleksii S. Rukhlenko, Sujoy Chatterjee, et al.
Science Advances (2023) Vol. 9, Iss. 39
Open Access | Times Cited: 7

All trans retinoic acid as a host-directed immunotherapy for tuberculosis
Ahmad Z. Bahlool, Conor Grant, Sally‐Ann Cryan, et al.
Current Research in Immunology (2022) Vol. 3, pp. 54-72
Open Access | Times Cited: 11

Host-directed therapies for tuberculosis: quantitative systems pharmacology approaches
Krina Mehta, Herman P. Spaink, Tom H. M. Ottenhoff, et al.
Trends in Pharmacological Sciences (2021) Vol. 43, Iss. 4, pp. 293-304
Open Access | Times Cited: 14

Endotypes of Paediatric Cough—Do They Exist and Finding New Techniques to Improve Clinical Outcomes
Hannah E. O’Farrell, Hing Cheong Kok, Suhani Goel, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 756-756
Open Access | Times Cited: 1

Gene Set Enrichment Analysis Reveals Individual Variability in Host Responses in Tuberculosis Patients
Teresa Domaszewska, Joanna Żyła, Raik Otto, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 8

Epigenetics of Pulmonary Tuberculosis
Madan M. Gupta, Ritu Gilhotra, Deepika Deopa, et al.
(2023), pp. 127-144
Closed Access | Times Cited: 3

Pediatric Post-TB Lung Disease: Ready for Prime Time?
Refiloe Masekela, Anna M. Mandalakas
American Journal of Respiratory and Critical Care Medicine (2023) Vol. 207, Iss. 8, pp. 975-977
Open Access | Times Cited: 2

Gene expression signatures identify biologically and clinically distinct tuberculosis endotypes
Andrew R. DiNardo, Tanmay Gandhi, Jan Heyckendorf, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top